Guilherme Povala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guilherme Povala has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Bruna Bellaver
University of Pittsburgh, Pittsburgh, PA USA
5 shared publicationsBruno Zatt
Universidade Federal de Pelotas, Pelotas Brazil
5 shared publicationsPamela C.L. Ferreira
University of Pittsburgh, Pittsburgh, PA USA
5 shared publicationsBelen Pascual
Houston Methodist Research Institute, Houston, TX USA
4 shared publicationsBrian A. Gordon
Washington University in St. Louis School of Medicine, St. Louis, MO USA
4 shared publicationsDana Tudorascu
University of Pittsburgh, Pittsburgh, PA USA
4 shared publications
Latest Publications
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S9)
Universal tau PET scale (Uniτ) – The HEAD Study
Background: The HEAD study aims to collect a large dataset of multiple tau‐PET tracers to provide robust anchor values for tau‐PET harmonization. Here, we tested the hypothesis that anchoring two tau tracer uptake values using head‐to‐head measurements has the potential to generate an accurate universal tau‐PET scale, named Uniτ(tau).Methods: We assessed 200 individuals across the aging and AD spectrum (Training:HEAD data freeze 2.0, n=185; Testing:UPitt dataset (Gogola et al.), n=15) with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET. SUVRs were processed to a common 8mm FWHM, with inferior cerebellar gray matter as the reference region (Pascoal et al.). Uniτ explored two anchoring/harmonization methods. First, we examined within‐tracer anchoring by creating anchor values based on the mean SUVR of Youngs (<25 years) and 95th percentile voxels from cognitively impaired individuals. Second, we explored within‐ plus between‐tracer anchoring, employing linear (e.g., piecewise) and non‐linear regressions. To address the inherent problem of discontinuity of piecewise transformations, we implemented two smoothing methods at the inflection point between equations, transforming them into a continuous function.Results: Uniτ scale anchoring within‐tracer resulted in similar estimates for high values, but less accurate in the lower range (Figure 1,2). Anchoring within‐ plus between‐tracer improved estimate consistency, with the piecewise transformation generating the best results. The piecewise smoothing equation yielded estimates comparable to those obtained from the piecewise method without smoothing. This allowed for the use of a single formula. In addition, this leads to more robust results when the goal is to study longitudinal changes in the scale (data not shown). UPitt testing dataset showed similar results to the training set (Figure 3).Conclusion: Our preliminary findings suggest that anchoring tau‐PET values both within and between tracers has the potential to harmonize tau‐PET tracers, while preserving their characteristics. Currently, piecewise smoothing is the preferred method for Uniτ, but we are continuously fine‐tuning scale parameters as we acquire more data. The final scale parameters will be determined based on extensive training and testing data from multiple tracers. This cautious methodology holds the promise of delivering reliable, robust, and reproducible results, ensuring safe usage of the scale in clinical trials, and potentially paving the way for future use in clinical practice.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S9)
Open AccessUniversal tau PET scale (Uniτ) – The HEAD Study
Background: The HEAD study aims to collect a large dataset of multiple tau‐PET tracers to provide robust anchor values for tau‐PET harmonization. Here, we tested the hypothesis that anchoring two tau tracer uptake values using head‐to‐head measurements has the potential to generate an accurate universal tau‐PET scale, named Uniτ(tau).Methods: We assessed 200 individuals across the aging and AD spectrum (Training:HEAD data freeze 2.0, n=185; Testing:UPitt dataset (Gogola et al.), n=15) with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET. SUVRs were processed to a common 8mm FWHM, with inferior cerebellar gray matter as the reference region (Pascoal et al.). Uniτ explored two anchoring/harmonization methods. First, we examined within‐tracer anchoring by creating anchor values based on the mean SUVR of Youngs (<25 years) and 95th percentile voxels from cognitively impaired individuals. Second, we explored within‐ plus between‐tracer anchoring, employing linear (e.g., piecewise) and non‐linear regressions. To address the inherent problem of discontinuity of piecewise transformations, we implemented two smoothing methods at the inflection point between equations, transforming them into a continuous function.Results: Uniτ scale anchoring within‐tracer resulted in similar estimates for high values, but less accurate in the lower range (Figure 1,2). Anchoring within‐ plus between‐tracer improved estimate consistency, with the piecewise transformation generating the best results. The piecewise smoothing equation yielded estimates comparable to those obtained from the piecewise method without smoothing. This allowed for the use of a single formula. In addition, this leads to more robust results when the goal is to study longitudinal changes in the scale (data not shown). UPitt testing dataset showed similar results to the training set (Figure 3).Conclusion: Our preliminary findings suggest that anchoring tau‐PET values both within and between tracers has the potential to harmonize tau‐PET tracers, while preserving their characteristics. Currently, piecewise smoothing is the preferred method for Uniτ, but we are continuously fine‐tuning scale parameters as we acquire more data. The final scale parameters will be determined based on extensive training and testing data from multiple tracers. This cautious methodology holds the promise of delivering reliable, robust, and reproducible results, ensuring safe usage of the scale in clinical trials, and potentially paving the way for future use in clinical practice.
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S9)
Creating Universal Tau PET Scale (Uniτ) Parametric Images – The HEAD Study
Background: The HEAD study focuses on collecting an extensive dataset from various tau‐PET tracers, aiming to establish robust anchor values, which are essential for harmonizing tau‐PET measurements. Here, we aim to showcase the capability of converting 3D tau‐PET images into a common scale using the Universal Tau‐PET Scale, Uniτ (tau), and to use these 3D images to subsequently obtain ROIs as needed.Methods: We assessed 185 individuals across the aging and AD spectrum from the HEAD study, with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET tracers. Tau‐PET SUVR images were standardized to a common 8mm FWHM, using the inferior cerebellar gray matter as the reference region. We generated Uniτ Tau‐PET 3D images using a single formula based on Meta‐temporal parameters in two steps: first, within‐tracer anchoring based on young (<25 years) and cognitively impaired individuals; second, between‐tracer anchoring using a piecewise transformation from [18F]Flortaucipir to [18F]MK‐6240, with smoothing at the piecewise inflection point. Subsequently, we extracted mean Uniτ values from these 3D images for key ROIs, including meta‐temporal, mesial, temporo‐parietal, frontal, and Braak stages III‐VI. Finally, we correlated Uniτ values across ROIs between the two tracers to evaluate the accuracy of estimates from the voxel‐wise transformation.Results: The original SUVR images present large differences between the two tau‐PET tracers (Figure 1). However, upon applying the Uniτ piecewise transformation with smoothing to all brain voxels, we were able to reasonably harmonize these images to the Uniτ scale, substantially reducing visual variability. Notably, the mean Uniτ values for the ROIs extracted from these harmonized 3D tau‐PET brain images demonstrated a high level of association between the two tracers (Figure 2). Furthermore, estimates generated from ROIs or extracted from our 3D parametric Uniτ model yielded identical estimates (Figure 3).Conclusion: The strong associations between tracers after directly harmonizing 3D images to Uniτ scale using the piecewise transformation with smoothing, underscore the effectiveness of the proposed method. This approach provides a reliable and standardized way to compare tau‐PET data across different tracers. Our results indicate the feasibility of harmonizing 3D tau‐PET images without relying on pre‐established ROIs, overcoming the limitation of restricting the analysis to only few brain regions.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S9)
Open AccessCreating Universal Tau PET Scale (Uniτ) Parametric Images – The HEAD Study
Background: The HEAD study focuses on collecting an extensive dataset from various tau‐PET tracers, aiming to establish robust anchor values, which are essential for harmonizing tau‐PET measurements. Here, we aim to showcase the capability of converting 3D tau‐PET images into a common scale using the Universal Tau‐PET Scale, Uniτ (tau), and to use these 3D images to subsequently obtain ROIs as needed.Methods: We assessed 185 individuals across the aging and AD spectrum from the HEAD study, with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET tracers. Tau‐PET SUVR images were standardized to a common 8mm FWHM, using the inferior cerebellar gray matter as the reference region. We generated Uniτ Tau‐PET 3D images using a single formula based on Meta‐temporal parameters in two steps: first, within‐tracer anchoring based on young (<25 years) and cognitively impaired individuals; second, between‐tracer anchoring using a piecewise transformation from [18F]Flortaucipir to [18F]MK‐6240, with smoothing at the piecewise inflection point. Subsequently, we extracted mean Uniτ values from these 3D images for key ROIs, including meta‐temporal, mesial, temporo‐parietal, frontal, and Braak stages III‐VI. Finally, we correlated Uniτ values across ROIs between the two tracers to evaluate the accuracy of estimates from the voxel‐wise transformation.Results: The original SUVR images present large differences between the two tau‐PET tracers (Figure 1). However, upon applying the Uniτ piecewise transformation with smoothing to all brain voxels, we were able to reasonably harmonize these images to the Uniτ scale, substantially reducing visual variability. Notably, the mean Uniτ values for the ROIs extracted from these harmonized 3D tau‐PET brain images demonstrated a high level of association between the two tracers (Figure 2). Furthermore, estimates generated from ROIs or extracted from our 3D parametric Uniτ model yielded identical estimates (Figure 3).Conclusion: The strong associations between tracers after directly harmonizing 3D images to Uniτ scale using the piecewise transformation with smoothing, underscore the effectiveness of the proposed method. This approach provides a reliable and standardized way to compare tau‐PET data across different tracers. Our results indicate the feasibility of harmonizing 3D tau‐PET images without relying on pre‐established ROIs, overcoming the limitation of restricting the analysis to only few brain regions.
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Creating Universal Tau PET Scale (Uniτ) Parametric Images – The HEAD Study
Background: The HEAD study focuses on collecting an extensive dataset from various tau‐PET tracers, aiming to establish robust anchor values, which are essential for harmonizing tau‐PET measurements. Here, we aim to showcase the capability of converting 3D tau‐PET images into a common scale using the Universal Tau‐PET Scale, Uniτ (tau), and to use these 3D images to subsequently obtain ROIs as needed.Methods: We assessed 185 individuals across the aging and AD spectrum from the HEAD study, with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET tracers. Tau‐PET SUVR images were standardized to a common 8mm FWHM, using the inferior cerebellar gray matter as the reference region. We generated Uniτ Tau‐PET 3D images using a single formula based on Meta‐temporal parameters in two steps: first, within‐tracer anchoring based on young (18F]Flortaucipir to [18F]MK‐6240, with smoothing at the piecewise inflection point. Subsequently, we extracted mean Uniτ values from these 3D images for key ROIs, including meta‐temporal, mesial, temporo‐parietal, frontal, and Braak stages III‐VI. Finally, we correlated Uniτ values across ROIs between the two tracers to evaluate the accuracy of estimates from the voxel‐wise transformation.Results: The original SUVR images present large differences between the two tau‐PET tracers (Figure 1). However, upon applying the Uniτ piecewise transformation with smoothing to all brain voxels, we were able to reasonably harmonize these images to the Uniτ scale, substantially reducing visual variability. Notably, the mean Uniτ values for the ROIs extracted from these harmonized 3D tau‐PET brain images demonstrated a high level of association between the two tracers (Figure 2). Furthermore, estimates generated from ROIs or extracted from our 3D parametric Uniτ model yielded identical estimates (Figure 3).Conclusion: The strong associations between tracers after directly harmonizing 3D images to Uniτ scale using the piecewise transformation with smoothing, underscore the effectiveness of the proposed method. This approach provides a reliable and standardized way to compare tau‐PET data across different tracers. Our results indicate the feasibility of harmonizing 3D tau‐PET images without relying on pre‐established ROIs, overcoming the limitation of restricting the analysis to only few brain regions.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Open AccessCreating Universal Tau PET Scale (Uniτ) Parametric Images – The HEAD Study
Background: The HEAD study focuses on collecting an extensive dataset from various tau‐PET tracers, aiming to establish robust anchor values, which are essential for harmonizing tau‐PET measurements. Here, we aim to showcase the capability of converting 3D tau‐PET images into a common scale using the Universal Tau‐PET Scale, Uniτ (tau), and to use these 3D images to subsequently obtain ROIs as needed.Methods: We assessed 185 individuals across the aging and AD spectrum from the HEAD study, with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET tracers. Tau‐PET SUVR images were standardized to a common 8mm FWHM, using the inferior cerebellar gray matter as the reference region. We generated Uniτ Tau‐PET 3D images using a single formula based on Meta‐temporal parameters in two steps: first, within‐tracer anchoring based on young (18F]Flortaucipir to [18F]MK‐6240, with smoothing at the piecewise inflection point. Subsequently, we extracted mean Uniτ values from these 3D images for key ROIs, including meta‐temporal, mesial, temporo‐parietal, frontal, and Braak stages III‐VI. Finally, we correlated Uniτ values across ROIs between the two tracers to evaluate the accuracy of estimates from the voxel‐wise transformation.Results: The original SUVR images present large differences between the two tau‐PET tracers (Figure 1). However, upon applying the Uniτ piecewise transformation with smoothing to all brain voxels, we were able to reasonably harmonize these images to the Uniτ scale, substantially reducing visual variability. Notably, the mean Uniτ values for the ROIs extracted from these harmonized 3D tau‐PET brain images demonstrated a high level of association between the two tracers (Figure 2). Furthermore, estimates generated from ROIs or extracted from our 3D parametric Uniτ model yielded identical estimates (Figure 3).Conclusion: The strong associations between tracers after directly harmonizing 3D images to Uniτ scale using the piecewise transformation with smoothing, underscore the effectiveness of the proposed method. This approach provides a reliable and standardized way to compare tau‐PET data across different tracers. Our results indicate the feasibility of harmonizing 3D tau‐PET images without relying on pre‐established ROIs, overcoming the limitation of restricting the analysis to only few brain regions.
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Universal tau PET scale (Uniτ) – The HEAD Study
Background: The HEAD study aims to collect a large dataset of multiple tau‐PET tracers to provide robust anchor values for tau‐PET harmonization. Here, we tested the hypothesis that anchoring two tau tracer uptake values using head‐to‐head measurements has the potential to generate an accurate universal tau‐PET scale, named Uniτ(tau).Methods: We assessed 200 individuals across the aging and AD spectrum (Training: HEAD data freeze 2.0, n=185; Testing: UPitt dataset (Gogola et al.), n=15) with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET. SUVRs were processed to a common 8mm FWHM, with inferior cerebellar gray matter as the reference region (Pascoal et al.). Uniτ explored two anchoring/harmonization methods. First, we examined within‐tracer anchoring by creating anchor values based on the mean SUVR of Youngs (<25 years) and 95th percentile voxels from cognitively impaired individuals. Second, we explored within‐ plus between‐tracer anchoring, employing linear (e.g., piecewise) and non‐linear regressions. To address the inherent problem of discontinuity of piecewise transformations, we implemented two smoothing methods at the inflection point between equations, transforming them into a continuous function.Results: Uniτ scale anchoring within‐tracer resulted in similar estimates for high values, but less accurate in the lower range (Figure 1,2). Anchoring within‐ plus between‐tracer improved estimate consistency, with the piecewise transformation generating the best results. The piecewise smoothing equation yielded estimates comparable to those obtained from the piecewise method without smoothing. This allowed for the use of a single formula. In addition, this leads to more robust results when the goal is to study longitudinal changes in the scale (data not shown). UPitt testing dataset showed similar results to the training set (Figure 3).Conclusion: Our preliminary findings suggest that anchoring tau‐PET values both within and between tracers has the potential to harmonize tau‐PET tracers, while preserving their characteristics. Currently, piecewise smoothing is the preferred method for Uniτ, but we are continuously fine‐tuning scale parameters as we acquire more data. The final scale parameters will be determined based on extensive training and testing data from multiple tracers. This cautious methodology holds the promise of delivering reliable, robust, and reproducible results, ensuring safe usage of the scale in clinical trials, and potentially paving the way for future use in clinical practice.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S2)
Open AccessUniversal tau PET scale (Uniτ) – The HEAD Study
Background: The HEAD study aims to collect a large dataset of multiple tau‐PET tracers to provide robust anchor values for tau‐PET harmonization. Here, we tested the hypothesis that anchoring two tau tracer uptake values using head‐to‐head measurements has the potential to generate an accurate universal tau‐PET scale, named Uniτ(tau).Methods: We assessed 200 individuals across the aging and AD spectrum (Training: HEAD data freeze 2.0, n=185; Testing: UPitt dataset (Gogola et al.), n=15) with [18F]Flortaucipir and [18F]MK‐6240 tau‐PET. SUVRs were processed to a common 8mm FWHM, with inferior cerebellar gray matter as the reference region (Pascoal et al.). Uniτ explored two anchoring/harmonization methods. First, we examined within‐tracer anchoring by creating anchor values based on the mean SUVR of Youngs (<25 years) and 95th percentile voxels from cognitively impaired individuals. Second, we explored within‐ plus between‐tracer anchoring, employing linear (e.g., piecewise) and non‐linear regressions. To address the inherent problem of discontinuity of piecewise transformations, we implemented two smoothing methods at the inflection point between equations, transforming them into a continuous function.Results: Uniτ scale anchoring within‐tracer resulted in similar estimates for high values, but less accurate in the lower range (Figure 1,2). Anchoring within‐ plus between‐tracer improved estimate consistency, with the piecewise transformation generating the best results. The piecewise smoothing equation yielded estimates comparable to those obtained from the piecewise method without smoothing. This allowed for the use of a single formula. In addition, this leads to more robust results when the goal is to study longitudinal changes in the scale (data not shown). UPitt testing dataset showed similar results to the training set (Figure 3).Conclusion: Our preliminary findings suggest that anchoring tau‐PET values both within and between tracers has the potential to harmonize tau‐PET tracers, while preserving their characteristics. Currently, piecewise smoothing is the preferred method for Uniτ, but we are continuously fine‐tuning scale parameters as we acquire more data. The final scale parameters will be determined based on extensive training and testing data from multiple tracers. This cautious methodology holds the promise of delivering reliable, robust, and reproducible results, ensuring safe usage of the scale in clinical trials, and potentially paving the way for future use in clinical practice.
- Open Access
- 11 December 2021
- Published by Springer Nature in Cell & Bioscience
- Vol. 11 (1) , 1-13
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Background: Changes in soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) are detectable at early preclinical stages of Alzheimer’s disease (AD). However, whether Aβ levels can predict downstream AD pathological features in cognitively unimpaired (CU) individuals remains unclear. With this in mind, we aimed at investigating whether a combination of soluble Aβ isoforms can predict tau pathology (T+) and neurodegeneration (N+) positivity.Methods: We used CSF measurements of three soluble Aβ peptides (Aβ1–38, Aβ1–40and Aβ1–42) in CU individuals (n = 318) as input features in machine learning (ML) models aiming at predicting T+ and N+. Input data was used for building 2046 tuned predictive ML models with a nested cross-validation technique. Additionally, proteomics data was employed to investigate the functional enrichment of biological processes altered in T+ and N+ individuals.Results: Our findings indicate that Aβ isoforms can predict T+ and N+ with an area under the curve (AUC) of 0.929 and 0.936, respectively. Additionally, proteomics analysis identified 17 differentially expressed proteins (DEPs) in individuals wrongly classified by our ML model. More specifically, enrichment analysis of gene ontology biological processes revealed an upregulation in myelinization and glucose metabolism-related processes in CU individuals wrongly predicted as T+. A significant enrichment of DEPs in pathways including biosynthesis of amino acids, glycolysis/gluconeogenesis, carbon metabolism, cell adhesion molecules and prion disease was also observed.Conclusions: Our results demonstrate that, by applying a refined ML analysis, a combination of Aβ isoforms can predict T+ and N+ with a high AUC. CSF proteomics analysis highlighted a promising group of proteins that can be further explored for improving T+ and N+ prediction.
- 11 December 2021
- Published by Springer Nature in Cell & Bioscience
- Vol. 11 (1) , 1-13
Open AccessSoluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Background: Changes in soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) are detectable at early preclinical stages of Alzheimer’s disease (AD). However, whether Aβ levels can predict downstream AD pathological features in cognitively unimpaired (CU) individuals remains unclear. With this in mind, we aimed at investigating whether a combination of soluble Aβ isoforms can predict tau pathology (T+) and neurodegeneration (N+) positivity.Methods: We used CSF measurements of three soluble Aβ peptides (Aβ1–38, Aβ1–40and Aβ1–42) in CU individuals (n = 318) as input features in machine learning (ML) models aiming at predicting T+ and N+. Input data was used for building 2046 tuned predictive ML models with a nested cross-validation technique. Additionally, proteomics data was employed to investigate the functional enrichment of biological processes altered in T+ and N+ individuals.Results: Our findings indicate that Aβ isoforms can predict T+ and N+ with an area under the curve (AUC) of 0.929 and 0.936, respectively. Additionally, proteomics analysis identified 17 differentially expressed proteins (DEPs) in individuals wrongly classified by our ML model. More specifically, enrichment analysis of gene ontology biological processes revealed an upregulation in myelinization and glucose metabolism-related processes in CU individuals wrongly predicted as T+. A significant enrichment of DEPs in pathways including biosynthesis of amino acids, glycolysis/gluconeogenesis, carbon metabolism, cell adhesion molecules and prion disease was also observed.Conclusions: Our results demonstrate that, by applying a refined ML analysis, a combination of Aβ isoforms can predict T+ and N+ with a high AUC. CSF proteomics analysis highlighted a promising group of proteins that can be further explored for improving T+ and N+ prediction.
- 7 December 2020
- Published by Wiley in Alzheimer's & Dementia
- Vol. 16 (S4)
A novel method for integrating transcriptomics and neuroimaging
Background: Positron emission tomography (PET) imaging has been playing a fundamental role in diagnosis of Alzheimer’s disease (AD). Also, in the context of AD, blood‐based biomarkers that are capable of predicting PET brain imaging findings are of high interest. Both PET imaging and transcriptomics are rich sources of different biological information. Hence, an interesting strategy to find potential novel blood biomarkers is by integrating PET imaging data with blood transcriptomics. We aim to develop a method for combining blood transcriptomics profile and PET imaging data, which may highlight novel AD biomarkers. Here, we hypothesize that by integrating blood transcriptomics and PET imaging data we will be able to identify clinically relevant novel peripheral biomarkers.Method: Imaging and transcriptomics data were acquired from Alzheimer’s Disease Neuroimaging Initiative (ADNI). Microarray gene expression profiling from blood samples of 69 cognitively unimpaired (CU) individuals and 158 mild cognitively impaired (MCI) were submitted to differential expression (DE) analysis using the limma R package. The [F18]FDG‐PET standardized uptake ratio (SUVr), using cerebellum as the reference region, were calculated. Genes obtained from DE analysis were selected to undergo integration with [F18]FDG‐PET images using voxel‐wise generalized linear regressions (GLR) (RMINC package).Results: The DE analysis resulted in 1232 differentially expressed genes (DEGs) (p‐value < 0.05). The GLR computed the associations between gene expression and [F18]FDG for each voxel, resulting in t‐value maps. Afterwards, only gray matter voxels presenting absolute t‐values higher than 2.3 were retained. Then, we transformed t‐value maps into proportion maps. In brief, each volume of interest (VOI) shows the percentage of voxels statistically correlated with gene expression (see Figure 1). Finally, we ranked DEGs according to the amount of VOIs with a proportion higher than 30%.Conclusion: With the use of the proposed method, we were able to integrate blood transcriptomics with PET neuroimaging. The implementation of this method shows great potential in the search for new blood biomarkers, which can accelerate early diagnosis and provides a template for future research in the field.
- 7 December 2020
- Published by Wiley in Alzheimer's & Dementia
- Vol. 16 (S4)
A novel method for integrating transcriptomics and neuroimaging
Background: Positron emission tomography (PET) imaging has been playing a fundamental role in diagnosis of Alzheimer’s disease (AD). Also, in the context of AD, blood‐based biomarkers that are capable of predicting PET brain imaging findings are of high interest. Both PET imaging and transcriptomics are rich sources of different biological information. Hence, an interesting strategy to find potential novel blood biomarkers is by integrating PET imaging data with blood transcriptomics. We aim to develop a method for combining blood transcriptomics profile and PET imaging data, which may highlight novel AD biomarkers. Here, we hypothesize that by integrating blood transcriptomics and PET imaging data we will be able to identify clinically relevant novel peripheral biomarkers.Method: Imaging and transcriptomics data were acquired from Alzheimer’s Disease Neuroimaging Initiative (ADNI). Microarray gene expression profiling from blood samples of 69 cognitively unimpaired (CU) individuals and 158 mild cognitively impaired (MCI) were submitted to differential expression (DE) analysis using the limma R package. The [F18]FDG‐PET standardized uptake ratio (SUVr), using cerebellum as the reference region, were calculated. Genes obtained from DE analysis were selected to undergo integration with [F18]FDG‐PET images using voxel‐wise generalized linear regressions (GLR) (RMINC package).Results: The DE analysis resulted in 1232 differentially expressed genes (DEGs) (p‐value < 0.05). The GLR computed the associations between gene expression and [F18]FDG for each voxel, resulting in t‐value maps. Afterwards, only gray matter voxels presenting absolute t‐values higher than 2.3 were retained. Then, we transformed t‐value maps into proportion maps. In brief, each volume of interest (VOI) shows the percentage of voxels statistically correlated with gene expression (see Figure 1). Finally, we ranked DEGs according to the amount of VOIs with a proportion higher than 30%.Conclusion: With the use of the proposed method, we were able to integrate blood transcriptomics with PET neuroimaging. The implementation of this method shows great potential in the search for new blood biomarkers, which can accelerate early diagnosis and provides a template for future research in the field.